Get Level 2

SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Rtw Biotech Share Price
  4. Rtw Biotech Share Regulatory News
  5. Spectris

Pin to quick picksRtw Biotech Regulatory News (RTW)

Rtw Biotech Information

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Spectris

1 Dec 2025 18:00

RNS Number : 7232J
FTSE Russell
01 December 2025
 

 

 

Further to the FTSE Russell notice released on 25 November 2025 in relation to Spectris (UK): Constituent Deletion, please note the FTSE 250 Index replacement and associated changes.

 

All other details remain unchanged. Please see updated notice below:

Spectris (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

01 December 2025

Subject to court sanctioning the scheme of arrangement for the cash offer for Spectris (UK, constituent) by Aurora Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

Spectris (UK, 0330860) will be deleted from the FTSE 250 Index.

 

RTW Biotech Opportunities (UK, BKTRRM2) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes effective from the open of Thursday 04 December 2025.

 

Full details of changes are available on the FTSE Russell website.

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSTBBJTMTMMBIA
12345678910
Date   Source Headline
27th Sep 20247:00 amRNSBioAge Labs completes $198 million IPO
26th Sep 20247:00 amRNSGBP quote for the share class to cease
16th Sep 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Sep 20247:00 amRNSHalf-year Report
14th Aug 20247:01 amRNSClosed Period Notification
14th Aug 20247:00 amRNSMonthly Valuation Update and Factsheet
6th Aug 20247:00 amRNSNew Investment in Jade Biosciences, Inc
22nd Jul 202412:00 pmRNSArtiva Biotherapeutics prices IPO at $167 million
15th Jul 20247:00 amRNSMonthly Valuation Update and Factsheet
11th Jul 20247:00 amRNSBaroness Blackwood Appointed as Independent NED
2nd Jul 20247:00 amRNSInvestment in Mirador Therapeutics & Santa Ana Bio
1st Jul 20247:00 amRNSTotal Voting Rights
14th Jun 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Jun 20247:00 amRNSPositive Data Announcement - Avidity Biosciences
11th Jun 20247:00 amRNSPortfolio Company Numab Therapeutics Update
5th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 202412:00 pmRNSDirector Declaration
31st May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSHolding(s) in Company
24th May 202412:00 pmRNSCancellation of Own Shares
16th May 20244:47 pmRNSResult of AGM
15th May 20247:01 amRNSTransaction in Own Shares
15th May 20247:00 amRNSAdditional Investment in Lycia Therapeutics
14th May 20247:00 amRNSMonthly Valuation Update and Factsheet
1st May 20247:01 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:46 pmRNSAnnual Financial Report
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20249:30 amRNSNotice of AGM
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSMonthly Valuation Update and First Quarter Letter
12th Apr 20245:42 pmRNSPortfolio Company Update: Artios Pharma
12th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSNew Investment: Obsidian Therapeutics
5th Apr 20247:01 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:01 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
WK57
Citi Fun 26
LSE
0.00%
FI65
Morg.st.b.v 26
LSE
0.00%
GM76
Citi Fun 26
LSE
0.00%
DU73
Citi Fun 26
LSE
0.00%
BD44
Greek 7%1924
LSE
0.00%
Trending
IMM
Immupharma
LSE
5.42%
AVCT
Avacta Group
LSE
3.65%
ITV
ITV
LSE
0.79%
CPAI
Capai
LSE
-2.22%
RR.
Rolls-Royce
LSE
4.41%